help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, Y. C.
Right arrow Articles by Orci, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, Y. C.
Right arrow Articles by Orci, L.

Endocrinology, Vol 104, 676-679, Copyright © 1979 by Endocrine Society


ARTICLES

Somatostatin secretion from monolayer cultures of neonatal rat pancreas

YC Patel, M Amherdt and L Orci

Monolayer cultures of neonatal rat pancreas have been characterized as an in vitro system for studying SRIF secretion. Marked 12- and 6-fold potentiation of SRIF release occurred with N-2-O-dibutyryl cAMP monosodium salt and theophylline, respectively. High glucose (300 mg/dl) stimulated SRIF release, whereas galactose was without effect. Exogenous insulin did not alter SRIF release, and the SRIF responses to theophylline and glucose were unaffected by the addition of antiinsulin serum to neutralize the insulin released by these agents. Arginine evoked a significant 2-fold increase in SRIF release. Exogenous glucagon produced slight but not significant stimulation of SRIF release. However, after exposure of the cultures to antiglucagon serum to diminish the concentration of glucagon in contact with the SRIF cells, exogenous glucagon produced a marked enhancement of SRIF secretion. These data suggest that glucose, arginine, glucagon, N-2-O- dibutyryl cAMP monosodium salt, and theophylline stimulate SRIF secretion, probably by direct effects on D cells or through mechanisms other than increased insulin secretion. Monolayer cultures of rat pancreas should provide a powerful in vitro system for studying pancreatic SRIF physiology.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
X. Ma, Y. Zhang, J. Gromada, S. Sewing, P.-O. Berggren, K. Buschard, A. Salehi, J. Vikman, P. Rorsman, and L. Eliasson
Glucagon Stimulates Exocytosis in Mouse and Rat Pancreatic {alpha}-Cells by Binding to Glucagon Receptors
Mol. Endocrinol., January 1, 2005; 19(1): 198 - 212.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Julien, J. Laine, and J. Morisset
Regulation of Rat Pancreatic CCKB Receptor and Somatostatin Expression by Insulin
Diabetes, June 1, 2004; 53(6): 1526 - 1534.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. B. Usdin, J. Hilton, T. Vertesi, G. Harta, G. Segre, and E. Mezey
Distribution of the Parathyroid Hormone 2 Receptor in Rat: Immunolocalization Reveals Expression by Several Endocrine Cells
Endocrinology, July 1, 1999; 140(7): 3363 - 3371.
[Abstract] [Full Text]


Home page
ScienceHome page
Y. Patel, M Amherdt, and L Orci
Quantitative electron microscopic autoradiography of insulin, glucagon, and somatostatin binding sites on islets
Science, September 17, 1982; 217(4565): 1155 - 1156.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society